Sign up
Quantellect · Congress · Trade Detail
HCPHCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142
DemocratHouse

Lois Frankel sold HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP)

Lois Frankel (D-FL), a U.S. Representative, has disclosed 3 trades in HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP) since 2015, 1 purchase and 2 sales, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Lois Frankel sold $1,001 - $15,000 of HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP) on February 16, 2016. Since that trade, HCP is up +0.00% against the S&P 500 up +354.76%, an outperformance of -354.76%.

Across these filings, Lois Frankel has been a net seller of HCP (a buy-to-sell ratio of 0.50). The most recent disclosed HCP transaction shown was dated May 4, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

HCP trades
3
Disclosed Vol
$24K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2015–2016

Lois Frankel's HCP trades vs the price

HCP is up +0.00% since Lois Frankel sold on February 16, 2016, versus +354.76% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+354.76%
Outperformance vs S&P 500
-354.76%

All Lois Frankel HCP trades

TradedTypeSizeReturnEst. profit
May 4, 2016SELL$1,001 - $15,000N/A
February 16, 2016SELL$1,001 - $15,000N/A
June 17, 2015BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Lois Frankel & HCP trading FAQ

Is it legal for Lois Frankel to trade HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP) stock?

Yes. Members of Congress are allowed to trade individual stocks, including HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Lois Frankel sell HCP?

Lois Frankel disclosed a sale of $1,001 - $15,000 of HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP) on February 16, 2016, according to public STOCK Act filings.

How has HCP performed since Lois Frankel's trade?

Since Lois Frankel sold HCP on February 16, 2016, the stock is up +0.00%, versus +354.76% for the S&P 500 over the same period, an outperformance of -354.76%.

How many times has Lois Frankel traded HCP?

Lois Frankel has disclosed 3 HCP trades since 2015 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional HCP trades?

Quantellect tracks every disclosed congressional trade in HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 (HCP) on the HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142 congressional trading page, which aggregates filings across all members of Congress.

Lois Frankel's HCP tradesAll congressional filings for HCP, Inc. (HCP) F ILING s TATus : New s ubHoLDING o F : Morgan stanley IRA - X142Lois Frankel's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.